Go to Top

Iproteos, is one of the 31 new technological spin-off companies launched in 2011 with support from ACC1Ó, the agency set up by the Catalan Government to promote competitiveness among enterprises.
ACC1Ó fosters the establishment and growth of new technology-based companies in Catalonia, enabling technology transfer from basic research and universities into the business world. This is achieved promoting the generation of new technology-based spin-off companies, which bring new products to the market, or through the incorporation of new technology, through patent license agreements, to an existing company, helping innovation in product and processes.

News

Iproteos has been selected to participate in Commercialise Project

Iproteos has been selected to participate, among other 14 SME spanish companies, in the Commercialise Project, an innovative and pioneering coaching and mentoring program whose main purpose is to speed up and increase the commercialization of R&D&i projects.

Commercialise Project is embedded into the Horizon 2020 and is currently being developed by other EU countries, such as United Kingdom, Denmark, Finland, Poland and Turkey.

Further information can be found

Read More

Iproteos’ CEO, Teresa Tarrago, interviewed in “Tot és possible” at RAC1 radio

Iproteos’ CEO, Teresa Tarrago, has been invited and interviewed at radio program named “Tot és possible” (Everything is possible) at RAC1. The interview covers topics such as the difficulties to find financing for a new biomedical company and the current status of the various research lines carried out by Iproteos.
More information can be found elsewhere:

http://www.irbbarcelona.org/index.php/en/news/irb-in-the-media/interview-with-teresa-tarrago-in-tot-es-possible

Photos taken along the interview
       

Read More

Events

Iproteos is attending BioEurope Meeting in Turin

 

Iproteos is attending BioEurope Spring Meeting conference that will be held in Turin (Italy) at 10 -12 March 2014. The BioEurope Spring conference is an excellent opportunity to make networking and meet  with dealmakers from other biotech, pharma and finance companies.

Further information can be found at:

http://www.ebdgroup.com/bes/index.php

Read More

Iproteos is attending BioEurope Conference in Viena

Iproteos is attending BioEurope Conference, that will be held in Viena (Austria) on 3th-4th of November 2013.
The annual BioEurope conference attracts leading dealmakers from biotech, pharma and finance, along with the most exciting emerging companies.
Further information can be found at:

http://www.ebdgroup.com/bioeurope/index.php

 

 

Read More